Philippe Armand

17PUBLICATIONS
72CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursLiquid biopsiesCardiovascular medicine and haematology not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 25, 2026
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin.

|Dec 31, 2024
Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma.

Julia Paczkowska, Ming Tang, Kyle T Wright

|Dec 07, 2024
Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.

Matthew S Davids, Christine E Ryan, Benjamin L Lampson

|Aug 16, 2023
Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement.

Christine E Ryan, Rebecca L Zon, Robert Redd

|Feb 02, 2023
Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors.

Deepti Gadi, Stephen P Martindale, Pui Yan Chiu

|Nov 08, 2022
Unresolved questions in the second-line use of CAR-T cells for diffuse large B cell lymphoma.

Edward R Scheffer Cliff, Reid W Merryman, Philippe Armand

Pageof 3

Frequent Collaborators

4 joint publications

Reid W Merryman

3 joint publications

Jennifer R Brown

3 joint publications

Matthew S Davids

3 joint publications

Yi-Bin Chen